ICD-10 Code B37.89 | Other sites of candidiasis Symptoms, Diagnosis, Billing

Other sites of candidiasis refers to fungal infections caused by Candida species that occur in locations outside the typical mucosal areas, such as the skin, nails, or other body sites. This condition is clinically significant as it can indicate systemic involvement or immunocompromised states. Accurate coding with ICD-10 Code B37.89 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can track and manage these infections effectively.

What is ICD-10 Code B37.89 for Other sites of candidiasis?

ICD-10 Code B37.89 represents Other sites of candidiasis, which encompasses Candida infections occurring in atypical locations beyond the oral cavity, gastrointestinal tract, or genital areas. This code should be used when documenting cases of candidiasis that do not fit into more specific categories, ensuring accurate clinical documentation and appropriate billing for treatment and management of the condition.

ICD-10 Code B37.89 – Clinical Definition and Explanation of Other sites of candidiasis

Other sites of candidiasis are caused by the overgrowth of Candida species, often due to factors such as antibiotic use, immunosuppression, or diabetes. This condition can progress to more severe infections if not addressed promptly, necessitating medical intervention.

Key Clinical Features:

• Presence of erythematous lesions or rashes in atypical locations.
• Possible systemic symptoms such as fever or malaise.
• History of immunosuppression or recent antibiotic use.
• Nail infections or skin infections that are persistent or recurrent.

ICD-10 Code B37.89 for Other sites of candidiasis – SOAP Notes & Clinical Use

ICD-10 Code B37.89 is utilized in SOAP notes to document the presence of candidiasis in non-standard sites. It plays a crucial role in capturing symptoms, assessments, and treatment plans, relevant in both acute and chronic care settings.

What Does ICD-10 Code B37.89 for Other sites of candidiasis Mean in SOAP Notes?

In SOAP notes, ICD-10 Code B37.89 connects subjective reports of symptoms and objective clinical findings to a formal diagnosis of candidiasis in atypical sites. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code B37.89 – Other sites of candidiasis

Prompt treatment of Other sites of candidiasis is essential to prevent complications and manage symptoms effectively.

Antibiotic Therapy:

• Fluconazole: 150 mg orally once for uncomplicated cases.
• Itraconazole: 200 mg daily for 3-6 months for chronic cases.
• Voriconazole: 200 mg twice daily for severe infections.

Supportive Care:

• Topical antifungal creams for localized infections.
• Proper hygiene and skin care to prevent recurrence.
• Monitoring blood glucose levels in diabetic patients.

Infection Control:

• Educate patients on hygiene practices to prevent spread.
• Isolate patients with systemic candidiasis in healthcare settings.
• Implement hand hygiene protocols among healthcare workers.

How to Document Symptoms of Other sites of candidiasis (ICD-10 B37.89) in SOAP Notes

Subjective:

• Patient reports persistent itching and redness in skin folds.
• History of recent antibiotic use for a bacterial infection.
• Complaints of nail discoloration and brittleness.
• No known allergies reported.

Objective:

• Erythematous lesions noted on physical examination.
• Nail examination reveals thickening and discoloration.
• Vital signs stable; no fever present.
• Skin scraping positive for Candida species.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Other sites of candidiasis (ICD-10 Code B37.89)

Assessment:

• Diagnosis: Other sites of candidiasis, moderate severity.
• ICD-10 Code: B37.89.
• Contributing factors: Recent antibiotic therapy and diabetes.
• Monitor for potential systemic involvement.

Plan:

• Initiate fluconazole 150 mg orally once.
• Educate patient on skin care and hygiene practices.
• Schedule follow-up in 2 weeks to assess treatment response.
• Consider referral to a dermatologist if no improvement.

Treatment & Plan Section for ICD-10 Code B37.89 – Other sites of candidiasis

• First-line treatment includes fluconazole or itraconazole.
• Non-pharmacologic strategies include maintaining skin dryness and hygiene.
• Monitor treatment response through follow-up appointments.
• Educate patients on recognizing early signs of recurrence.

Using ICD-10 Code B37.89 for Other sites of candidiasis in Billing & SOAP Note Compliance

• Ensure clear documentation of symptoms and clinical findings.
• Use the code in appropriate clinical settings, including outpatient and inpatient.
• Align treatment plans with clinical guidelines to support billing.
• Include relevant CPT codes that correspond to the services provided.

Related ICD-10 Codes Often Used with Other sites of candidiasis

• B37.0 – Oral candidiasis
• B37.1 – Esophageal candidiasis
• B37.7 – Candidiasis of the skin
• B37.81 – Candidiasis of the vagina

ICD-10 Code B37.89 in Medical Billing and Insurance for Other sites of candidiasis

ICD-10 Code B37.89 is critical in billing for candidiasis cases in hospital, ER, or infectious disease settings.

Billing Notes:

• Document all relevant clinical findings to support the diagnosis.
• Use this code in conjunction with other codes for comprehensive billing.
• Ensure that the documentation reflects the severity and treatment provided.
• Include patient history that may contribute to candidiasis development.

Common CPT Pairings: